Donepezil Enhances Purkinje Cell Survival and Alleviates Motor Dysfunction by Inhibiting Cholesterol Synthesis in a Murine Model of Niemann Pick Disease Type C
Authors:
Open Access
- 1 March 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 73 (3) , 234-243
Abstract
Neurodegenerative processes are often accompanied by disruption of cholinergic systems; therefore, acetylcholinesterase (AChE) inhibitors (AChEIs) may have therapeutic potential in some neurological conditions. We evaluated the effects of administration of donepezil, a widely used AChEI, in the cerebellum in a murine model of Niemann-Pick disease type C (NPC). The NPC mice developed Purkinje cell loss at the age of 8 weeks; 4-week-old NPC mice given donepezil led to improvement of Purkinje cell survival that was associated with improvement of motor dysfunction in the mice. Because abnormal accumulation of cholesterol caused by impaired lipid homeostasis is the principal pathogenetic mechanism underlying NPC, we investigated the effects of donepezil on cholesterol metabolism in the NPC mice. Donepezil treatment reduced cholesterol accumulation in adult neural stem cells in vitro, and it downregulated the expression of the cholesterol synthesis factors' sterol regulatory element-binding proteins and 3-hydroxy-3-methylglutaryl-CoA reductase in the cerebellum, implying that AChE activity might be associated with cholesterol homeostasis. Taken together, our findings suggest the role of a cholinergic pathway as a novel regulator of NPC progression and the potential application of AChEIs for the treatment of human NPC.Keywords
This publication has 43 references indexed in Scilit:
- The history of the cholinergic hypothesisBehavioural Brain Research, 2011
- Recommendations on the diagnosis and management of Niemann-Pick disease type CMolecular Genetics and Metabolism, 2009
- NPC1/NPC2 function as a tag team duo to mobilize cholesterolProceedings of the National Academy of Sciences, 2008
- Brainstem neuropathology in a mouse model of Niemann–Pick disease type CJournal of the Neurological Sciences, 2008
- Protective Effect of Donepezil on Retinal Ganglion CellsIn VitroandIn VivoCurrent Eye Research, 2006
- NPC1 Gene Deficiency Leads to Lack of Neural Stem Cell Self-Renewal and Abnormal Differentiation Through Activation of p38 Mitogen-Activated Protein Kinase SignalingStem Cells, 2005
- Role of Cholinesterase Inhibitors in Parkinson’s Disease and dementia with Lewy BodiesJournal of Geriatric Psychiatry and Neurology, 2004
- Niemann–Pick disease type CClinical Genetics, 2003
- The Cholinergic Hypothesis of Age and Alzheimer’s Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug DevelopmentThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Rivastigmine in the treatment of Huntington's diseaseEuropean Journal of Neurology, 2002